Vascular endothelial growth factor (VEGF)+405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 6213-6218

  Hamedian, Amir Abbas ^a   Esteghamati, Alireza ^b   Noshad, Sina ^b   Mozafari, Mohammad ^b   Moin Tavakkoli, Hosein ^b   Nakhjavani, Manouchehr ^b   Mahmoudi, Touraj ^c   Nikzamir, Mahfam ^d   Safary, Reza ^b   Nikzamir, Abdolrahim ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d National Organization for Development of Exceptional Talents   (Iran)

^e AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Essential hypertension; Single nucleotide polymorphism; Vascular endothelial growth factor

Indexed keywords

CHOLESTEROL; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; ALLELE; ANTHROPOMETRY; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED; POPULATION GENETICS; STATISTICAL MODEL;

ALLELES; ANTHROPOMETRY; DEMOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; HYPERTENSION; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863751256     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1440-8     Document Type: Article

References (29)

1. Coy V (2005) Genetics of essential hypertension. J Am Acad Nurse Pract 17:219-224
2. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB (2004) Genetics of essential hypertension. Hum Mol Genet 13 Spec No 1:R169-R175
3. Carretero OA, Oparil S (2000) Essential hypertension. Part I: definition and etiology. Circulation 101:329-335
4. Millis RM (2011) Epigenetics and hypertension. Curr Hypertens Rep 13:21-28
5. Caulfield M, Munroe P, Pembroke J et al (2003) Genome-wide mapping of human loci for essential hypertension. Lancet 361:2118-2123
6. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB (2003) Genes and hypertension. Curr Pharm Des 9:1679-1689
7. Samani NJ (2003) Genome scans for hypertension and blood pressure regulation. Am J Hypertens 16:167-171
8. Vincenti V, Cassano C, Rocchi M, Persico G (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493-1495
9. Lin TH, Su HM, Wang CL et al (2010) Vascular endothelial growth factor polymorphisms and extent of coronary atherosclerosis in Chinese population with advanced coronary artery disease. Am J Hypertens 23:960-966
10. Palmirotta R, Ferroni P, Ludovici G et al (2010) VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension. Clin Biochem 43:1090-1095
11. Awata T, Inoue K, Kurihara S et al (2002) A common polymorphism in the 50-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635-1639
12. Howell WM, Ali S, Rose-Zerilli MJ, Ye S (2005) VEGF polymorphisms and severity of atherosclerosis. J Med Genet 42: 485-490
13. Sandrim VC, Palei AC, Cavalli RC et al (2009) Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 15:115-120
14. American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28:S37-S42
15. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
16. Esteghamati A, Mansournia N, Nakhjavani M, et al (2011) Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes. Mol Biol Rep 2011 Jul 10. [Epub ahead of print]
17. Plouet J, Schilling J, Gospodarowicz D (1989) Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8:3801-3806
18. Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
19. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611
20. Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437:497-504
21. Gyurkovics M, Lohinai Z, Gyorfi A et al (2009) Venodilatory effect of vascular endothelial growth factor on rat gingiva. J Periodontol 80:1518-1523
22. Wongpiyabovorn J, Hirankarn N, Ruchusatsawat K et al (2011) The association of single nucleotide polymorphism within vascular endothelial growth factor gene with systemic lupus erythematosus and lupus nephritis. Int J Immunogenet 38:63-67
23. Lin TH, Wang CL, Su HM et al (2010) Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease. Clin Chim Acta 411:1688-1693
24. van der Meer P, De Boer RA, White HL et al (2005) The VEGF ?405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J Card Fail 11:279-284
25. Nikzamir A, Esteghamati A, Hammedian AA, Mahmoudi T (2011) The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus. Mol Biol Rep 2011 May 12. [Epub ahead of print]
26. Young HS, Summers AM, Bhushan M et al (2004) Singlenucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122:209-215
27. Han SW, Kim GW, Seo JS et al (2004) VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxf) 43:1173-1177
28. Salvarani C, Boiardi L, Casali B et al (2004) Vascular endothelial growth factor gene polymorphisms in Behçet's disease. J Rheumatol 31:1785-1789
29. Boiardi L, Casali B, Nicoli D et al (2003) Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 30:2160-2164